Literature DB >> 2056282

Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines.

A E Goldfeld1, J L Strominger, C Doyle.   

Abstract

The minimal region of the human tumor necrosis factor alpha (TNF-alpha) gene promoter necessary for its transcriptional induction by phorbol esters (PMA) in human T and B lymphocyte cell lines has been localized between -52 and +89 nucleotides (nt) relative to the gene's transcriptional start site. Comparison of these sequences to those required to mediate virus or lipopolysaccharide (LPS) induction of the gene reveal significant differences, and thus, the sequence requirements for PMA induction are distinct from those that mediate induction by virus or LPS. Although three sites in the TNF-alpha promoter (kappa 1, kappa 2, and kappa 3) specifically bind the transcription factor NF-kappa B in lymphoid nuclear extracts, TNF-alpha mRNA induction by PMA does not correlate with NF-kappa B binding activities displayed by different T and B cell lines. Moreover, kappa 1-kappa 3 can each be deleted from the TNF-alpha promoter with little effect on the gene's inducibility by PMA. Therefore, TNF-alpha mRNA induction by PMA, like its induction by virus and LPS, is not primarily mediated by NF-kappa B, but rather is mediated through other sequences and protein factors. Surprisingly, multimers of kappa 1-kappa 3 can confer PMA inducibility on a heterologous promoter in a B (Raji), but not a T (HUT78) cell line. However they are not functional on a truncated TNF-alpha promoter, indicating that promoter context and cell type specificity influence the PMA inducible function of these NF-kappa B binding sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056282      PMCID: PMC2118869          DOI: 10.1084/jem.174.1.73

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Tumor necrosis factors: gene structure and biological activities.

Authors:  D V Goeddel; B B Aggarwal; P W Gray; D W Leung; G E Nedwin; M A Palladino; J S Patton; D Pennica; H M Shepard; B J Sugarman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

Review 3.  The common mediator of shock, cachexia, and tumor necrosis.

Authors:  B Beutler; A Cerami
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

4.  Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.

Authors:  J W Pierce; M Lenardo; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells.

Authors:  G Hensel; D N Männel; K Pfizenmaier; M Krönke
Journal:  Lymphokine Res       Date:  1987

6.  HIV-1 infection does not induce tumor necrosis factor-alpha or interferon-beta gene transcription.

Authors:  A E Goldfeld; K Birch-Limberger; R T Schooley; B D Walker
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

7.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

8.  Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Authors:  S S Sung; J M Bjorndahl; C Y Wang; H T Kao; S M Fu
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

9.  B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF).

Authors:  P Poupart; P Vandenabeele; S Cayphas; J Van Snick; G Haegeman; V Kruys; W Fiers; J Content
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

10.  Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.

Authors:  S S Sung; L K Jung; J A Walters; W Chen; C Y Wang; S M Fu
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  40 in total

1.  A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment.

Authors:  F Myokai; S Takashiba; R Lebo; S Amar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers.

Authors:  Alla V Tsytsykova; Ricardo Rajsbaum; James V Falvo; Filipa Ligeiro; Simon R Neely; Anne E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

3.  The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus.

Authors:  Kathleen E Sullivan; April Suriano; Kelly Dietzmann; Janice Lin; Daniel Goldman; Michelle A Petri
Journal:  Clin Immunol       Date:  2007-02-05       Impact factor: 3.969

4.  Chromatin structure and DNase I hypersensitivity in the transcriptionally active and inactive porcine tumor necrosis factor gene locus.

Authors:  P Kuhnert; E Peterhans; U Pauli
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

5.  A novel splice variant of the transcription factor Nrf1 interacts with the TNFalpha promoter and stimulates transcription.

Authors:  E E Prieschl; V Novotny; R Csonga; D Jaksche; A Elbe-Bürger; W Thumb; M Auer; G Stingl; T Baumruker
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

Review 6.  Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis.

Authors:  T Hasunuma; T Kato; T Kobata; K Nishioka
Journal:  Springer Semin Immunopathol       Date:  1998

7.  TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB.

Authors:  Viraga Haridas; Polidy Pean; Luke D Jasenosky; Yoann Madec; Didier Laureillard; Thim Sok; Sun Sath; Laurence Borand; Olivier Marcy; Sarin Chan; Erdyni Tsitsikov; Jean-François Delfraissy; François-Xavier Blanc; Anne E Goldfeld
Journal:  AIDS       Date:  2015-01-28       Impact factor: 4.177

8.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter.

Authors:  A M Uglialoro; D Turbay; P A Pesavento; J C Delgado; F E McKenzie; J G Gribben; D Hartl; E J Yunis; A E Goldfeld
Journal:  Tissue Antigens       Date:  1998-10

9.  Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN.

Authors:  E Y Tsai; J Yie; D Thanos; A E Goldfeld
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Thalidomide inhibits the replication of human immunodeficiency virus type 1.

Authors:  S Makonkawkeyoon; R N Limson-Pobre; A L Moreira; V Schauf; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.